Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Biovie Inc (BIVI)

Biovie Inc (BIVI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8400 -0.0542 (-6.06%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8820 +0.0420 (+5.00%) 16:46 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.8377
Day High
0.8912
Open 0.8800
Previous Close 0.8942 0.8942
Volume 63,800 63,800
Avg Vol 199,855 199,855
Stochastic %K 77.44% 77.44%
Weighted Alpha -80.53 -80.53
5-Day Change -0.0008 (-0.10%) -0.0008 (-0.10%)
52-Week Range 0.6200 - 7.5000 0.6200 - 7.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,300
  • Shares Outstanding, K 18,452
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,120 K
  • EBIT $ -24 M
  • EBITDA $ -23 M
  • 60-Month Beta 0.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.62
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -9.76
  • Most Recent Earnings $-0.46 on 02/11/25
  • Next Earnings Date 05/13/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.32
  • Number of Estimates 1
  • High Estimate -0.32
  • Low Estimate -0.32
  • Prior Year -2.00
  • Growth Rate Est. (year over year) +84.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6200 +35.48%
on 04/07/25
Period Open: 1.1200
1.1235 -25.23%
on 03/26/25
-0.2800 (-25.00%)
since 03/25/25
3-Month
0.6200 +35.48%
on 04/07/25
Period Open: 1.9300
2.0400 -58.82%
on 02/05/25
-1.0900 (-56.48%)
since 01/24/25
52-Week
0.6200 +35.48%
on 04/07/25
Period Open: 4.8890
7.5000 -88.80%
on 10/21/24
-4.0490 (-82.82%)
since 04/25/24

Most Recent Stories

More News
New to The Street Airs on Bloomberg TV Saturday, April 26 at 6:30 PM ET Featuring BioVie (NASDAQ: BIVI), Skip Barber Racing School with CFO Michael Berg, CommercialVille.tv, Sustainable Green Team (OTCPK: SGTM) WaterLess Garden, and The Business of

Presented as Sponsored Programming by Bitdeer.

BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
BioVie Initiates SUNRISE-PD Clinical Trial Assessing Bezisterim in Early Parkinson’s Disease with First Patient Enrolled

BIVI : 0.8400 (-6.06%)
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI

Also debuting - our hospitality segment featuring BLACKBARN NYC with Chef John Doherty and a spotlight on The Sustainable Green Team (OTC PINK:SGTM) with Kevin Harrington and CEO Tony Raynor

HIT : 0.6641 (+0.62%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
EXOZ : 10.73 (-10.95%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice

New to The Street debuts its inaugural restaurant segment featuring BlackBarn with owner and chef John Doherty

RDZN : 0.9110 (+3.17%)
HIT : 0.6641 (+0.62%)
PETV : 0.5445 (+4.73%)
ACXP : 0.4046 (+0.72%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President

BlackBarn Restaurant NYC on 26th street The premiere restaurant segment with Owner and Head Chef John Doherty

RDZN : 0.9110 (+3.17%)
HIT : 0.6641 (+0.62%)
PETV : 0.5445 (+4.73%)
ACXP : 0.4046 (+0.72%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice

New Segment "Market Bites" Debuts with Chef John Doherty of BlackBarn Showcasing the Culinary Side of Business Leadership

RDZN : 0.9110 (+3.17%)
PETV : 0.5445 (+4.73%)
ACXP : 0.4046 (+0.72%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Sponsored by The Sustainable Green Team (OTC: SGTM), featuring Kevin Harrington - the ORIGINAL Shark from Shark Tank

RDZN : 0.9110 (+3.17%)
BIVI : 0.8400 (-6.06%)
TNXP : 17.82 (+3.66%)
SGTM : 0.0754 (+0.53%)
BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025

BIVI : 0.8400 (-6.06%)
New to The Street’s FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese’s The Big Skinny on eXoZymes, and Banzai CEO Joe

Sponsored by The Sustainable Green Team and Featuring an Exclusive Interview with Former Shark Kevin Harrington

RDZN : 0.9110 (+3.17%)
BNZI : 1.0000 (-2.91%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)

The Sustainable Green Team ($SGTM), with Kevin Harrington, "Original Shark Tank" Investor, and CEO Tony Raynor, Features Sponsor with Full Interview Link. Plus, the Debut of the New Roadzen $RDZN TV Commercial...

PETV : 0.5445 (+4.73%)
BNZI : 1.0000 (-2.91%)
BIVI : 0.8400 (-6.06%)
SGTM : 0.0754 (+0.53%)
ZAPP : 0.5331 (+0.13%)

Business Summary

BioVie Inc. engages in developing drug therapies for liver disease. The company's product candidate includes BIV201, which are in clinical stage. BioVie Inc. is based in SANTA MONICA, CA.

See More

Key Turning Points

3rd Resistance Point 0.9284
2nd Resistance Point 0.9098
1st Resistance Point 0.8749
Last Price 0.8400
1st Support Level 0.8214
2nd Support Level 0.8028
3rd Support Level 0.7679

See More

52-Week High 7.5000
Fibonacci 61.8% 4.8718
Fibonacci 50% 4.0600
Fibonacci 38.2% 3.2482
Last Price 0.8400
52-Week Low 0.6200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective